Form 4: DENTSPLY SIRONA Director Boosts XRAY Holdings

DENTSPLY SIRONA Director Michael J. Barber acquired 223.681 additional common shares through restricted stock unit dividends, increasing his total beneficial ownership to 17,699.171 shares.

Summary

• Michael J. Barber, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 223.681 shares of common stock.
• The acquisition occurred on October 10, 2025, at a price of $0 per share.
• These shares represent dividends on previously awarded restricted stock units (RSUs).
• The newly acquired RSU dividends are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Following this transaction, Mr. Barber beneficially owns a total of 17,699.171 shares of DENTSPLY SIRONA common stock.
• Each RSU converts to common stock on a 1:1 basis.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates increased director ownership, aligning interests with shareholders, but it's a routine, non-cash transaction (RSU dividends) rather than an open market purchase.

Positives

• Increased beneficial ownership by a director, aligning management interests with shareholders.
• The acquisition of shares through RSU dividends is a standard component of executive compensation, reflecting ongoing participation in the company's equity.

Negatives

• No direct negatives are indicated by this routine transaction.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The acquired RSU dividends are subject to the same vesting terms as the underlying awards, indicating future conversion to common stock upon satisfaction of these terms.

Industry Context

This transaction is a routine insider filing (Form 4) reporting a change in beneficial ownership due to RSU dividends, a common form of equity compensation for directors and executives across various industries, including medical devices and dental products. It reflects standard corporate governance practices regarding executive incentives.

Comparison to Industry Standards

• This type of RSU dividend acquisition is a standard practice for director compensation in publicly traded companies, aligning with common equity incentive plans.
• It does not represent an open market purchase or sale, but rather a mechanism to accrue additional equity based on existing RSU holdings.
• No specific comparable companies or projects are mentioned in the filing to allow for a direct comparison of results.

Related Party Transactions

• The transaction involves a director receiving equity compensation (RSU dividends), which is a standard related party transaction disclosed in this context.

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively as it aligns management's interests with shareholder value.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Next Steps

• The acquired RSU dividends will vest simultaneously with the underlying RSUs to which they relate, converting to common stock upon vesting.

Key Dates

Recommendation

This Form 4 reports a routine, non-cash acquisition of shares by a director through RSU dividends. While it slightly increases director ownership, which is generally positive for aligning interests, it does not represent a significant change in the company's operational or financial outlook, nor does it signal a strong conviction buy or sell from the director's perspective. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

DENTSPLY SIRONA, XRAY, Michael J. Barber, Director, Form 4, insider transaction, restricted stock units, RSU, common stock, beneficial ownership, dividends